Fumihiro Ozaki

Discovery of (1<i>R</i>,2<i>S</i>)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-<i>N</i>-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist

Yu Yoshida, Yoshimitsu Naoe, Taro Terauchi et al. · Journal of Medicinal Chemistry · 2015 · 84 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Inhibitors of Adhesion Molecules Expression; The Synthesis and Pharmacological Properties of 10H-Pyrazino[2,3-b][1,4]benzothiazine Derivatives.

Toshihiko Kaneko, Richard S. J. Clark, Norihito Ohi et al. · Chemical and Pharmaceutical Bulletin · 2002 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Design, synthesis, and structure–activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists

Yu Yoshida, Taro Terauchi, Yoshimitsu Naoe et al. · Bioorganic & Medicinal Chemistry · 2014 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

A novel antileukemic sesquiterpene lactone. Synthesis of racemic eriolanin

Takeshi Wakamatsu, Nobuhide Miyachi, Fumihiro Ozaki et al. · Tetrahedron Letters · 1988 · 20 citations

Pharmacy, Medicinal Chemistry, Pharmacology +7

Piperidine Carboxylic Acid Derivatives of 10H-Pyrazino[2,3-b][1,4]benzothiazine as Orally-Active Adhesion Molecule Inhibitors

Toshihiko Kaneko, Richard S. J. Clark, Norihito Ohi et al. · Chemical and Pharmaceutical Bulletin · 2004 · 14 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16